Full video transcriptClick to expand
Auto-generated transcript of @theslickric's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00I've heard a lot of people talking about T-Max and I'm gonna give you my update on it.
- 0:04I took C-Max for about three months and I took three vials of it of a nasal spray.
- 0:12And it's an interesting substance.
- 0:17I would say it's not what make people make it seem. It's unlike the limitless pill where you take it and out of the sudden you're going to be the most productive person.
- 0:26Every answer is going to come to your mind and you know you like find the answer to everything and everything.
- 0:34I would say it's more like a habit enhancer because it strengthens habits.
- 0:45Whether they are bad or right or productive or unproductive for you, it's gonna strengthen habits
- 0:54which I saw with both hands of it.
- 1:00Now it does feel slightly like a rush of dopamine to an extent like in a very sideways.
- 1:09It's not as similar to to Addero as people make it seem.
- 1:14It is not Addero without side effects right because I feel the main difference being that Addero makes you break the inerorship
- 1:23in between taking action and stagnation.
- 1:28At least for me right. As for C-Max I don't have that inertia breaking effect that any of the big three ADHD medications have like five unsateral riddling.
- 1:50I would say it feels like modafinoe as a feeling if I could put it in words.
- 2:04I also think that C-Max would be fantastic paired with another stimulant or another neutropic.
- 2:14I tried C-Lenk as well. I didn't try the nasal spray.
- 2:19I tried it injected because that was the only one I could find.
- 2:24It was okay as well. Obviously it doesn't have any side effects opposed to like benzos or pre-gabalin.
- 2:35That's good. C-Max doesn't have any side effects at least not that I could see an experience other than happy strengthened.
- 2:48It'll strengthen any habits you have whether good or bad.
- 2:52Now that's more of a user error if you indulge into bad habits.
- 2:58For people with ADD and ADHD typically the main problem is going from stagnation to action.
- 3:12Breaking that inertia is what I would say either vibes or a lateral or fantastic at.
- 3:24In my own case I would say that C-Max combined with another neutropic and a stimulant.
- 3:34Did the C-Max be a neuroprotective? Would be like a fantastic idea.
- 3:39But in my case I didn't really feel that it was what people made a team.
- 3:47I just feel it's a little over hyped if I'm being honest.
- 3:52Not saying it's bad it just feels a little bit over hyped.
- 3:56I was expecting something else and yes it was a clean, sustained but short lasting dopamine rush which helped you focus.
- 4:13Obviously nothing compared to like Adderall.
- 4:18But I think it has its use as long as it's paired with another stimulant.
- 4:26Whether that's coffee or Adderall or another neutropic.
- 4:30And I'm going to try bromontain.
- 4:33I'm just waiting on the order to be honest just to see how that goes and you know hopefully
- 4:41it being a replacement for Adderall but I mean we'll see.
- 4:50We'll see how that one goes.
Semax for ADHD: separating peptide hype from thin evidence
Quick answer
Semax is a synthetic ACTH-derived peptide with some evidence for neuroprotective effects in acute neurological injury, primarily from Russian clinical studies, but no peer-reviewed human trials support its use for ADHD or cognitive enhancement in healthy adults. The creator's subjective description of a mild, dopamine-adjacent focus effect is not inconsistent with its known mechanism of modulating BDNF and dopaminergic signaling, but this does not constitute a validated therapeutic effect. Stacking semax with prescription stimulants like Adderall without clinical oversight introduces unquantified cardiovascular and psychiatric risk.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Semax for ADHD: separating peptide hype from thin evidence, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Functional Connectomic Approach to Studying Selank and Semax Effects
Small Russian fMRI study (52 healthy volunteers) of brain connectivity after Semax or Selank; mechanistic and exploratory, not a clinical efficacy trial.
PubMed
Effects of Semax on the Default Mode Network of the Brain
Small human fMRI study (24 adults) of intranasal Semax on brain networks; an imaging-marker study with no clinical outcomes, not replicated outside the originating group.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
Semax for ADHD: separating peptide hype from thin evidence is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Semax for ADHD: separating peptide hype from thin evidence" from theslickric. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Semax is a synthetic ACTH-derived peptide with some evidence for neuroprotective effects in acute neurological injury, primarily from Russian clinical studies, but no peer-reviewed human trials support its use for ADHD or cognitive enhancement in healthy adults.
The reason this review is not generic is the source wording and the canonical claim label "peptides semax peptide adhd limitless nootropic." In this clip, the useful excerpt is: "I've heard a lot of people talking about T-Max and I'm gonna give you my update on it." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Functional Connectomic Approach to Studying Selank and Semax Effects (2020), Effects of Semax on the Default Mode Network of the Brain (2018), and Therapeutic Peptides: Applications, Challenges, and Future Directions (2026), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
Semax is a synthetic ACTH-derived peptide with some evidence for neuroprotective effects in acute neurological injury, primarily from Russian clinical studies, but no peer-reviewed human trials support its use for ADHD or cognitive enhancement in healthy adults.
FormBlends verdict
Peptide social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Semax is a synthetic ACTH-derived peptide with some evidence for neuroprotective effects in acute neurological injury, primarily from Russian clinical studies, but no peer-reviewed human trials support its use for ADHD or cognitive enhancement in healthy adults. The creator's subjective description of a mild, dopamine-adjacent focus effect is not inconsistent with its known mechanism of modulating BDNF and dopaminergic signaling, but this does not constitute a validated therapeutic effect. Stacking semax with prescription stimulants like Adderall without clinical oversight introduces unquantified cardiovascular and psychiatric risk.
- Semax is FDA-unapproved and exists in a US regulatory gray zone. It is approved only in Russia and Ukraine, for stroke and optic nerve conditions, not ADHD.
- The primary human evidence for semax comes from Russian clinical studies in acute neurological injury patients, not healthy adults seeking cognitive enhancement. This is a significant population mismatch.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Semax is FDA-unapproved and exists in a US regulatory gray zone. It is approved only in Russia and Ukraine, for stroke and optic nerve conditions, not ADHD.
- The primary human evidence for semax comes from Russian clinical studies in acute neurological injury patients, not healthy adults seeking cognitive enhancement. This is a significant population mismatch.
- Dolotov et al. (2006, Journal of Neurochemistry) confirmed semax modulates dopaminergic signaling and increases BDNF in animal models, which offers a plausible mechanism for the mild focus effect the creator described, but animal data does not equal human clinical benefit.
- Comparing semax to Adderall or Ritalin for ADHD is not supported by any clinical evidence. FDA-approved ADHD medications have decades of replicated randomized controlled trial data behind them. Semax has none for this indication.
- Stacking semax with prescription amphetamines without medical supervision is not a validated or safe protocol. The cardiovascular and psychiatric risks of combining dopaminergic agents in an unmonitored setting are real and unquantified.
- Selank, which the creator also tried, is a synthetic analog of tuftsin with anxiolytic properties studied in Russian literature. It does not act on GABA-A receptors like benzodiazepines, so the side-effect comparison to benzos is directionally fair, but it is not a validated anxiolytic substitute.
- Personal n=1 experience over three months with no control condition, no biomarkers, and no standardized cognitive testing cannot establish whether semax caused any observed effects or whether those effects would generalize to anyone else.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @theslickric actually say?
The creator spent three months using semax nasal spray, working through three vials, and came away underwhelmed. His core take: semax is not "the limitless pill." He described it as a "habit enhancer" that strengthens existing behaviors, good or bad. He said it produced "a clean, sustained but short lasting dopamine rush" and felt more like modafinil than Adderall. He also tried selank via injection and called it "okay." His conclusion was that semax is overhyped, especially for ADHD, where the main problem is breaking inertia, something he says semax doesn't do well. He floated the idea of stacking it with stimulants and mentioned wanting to try bromantane as a possible Adderall replacement.
Does the science back this up?
Partially, and it depends heavily on which claim you're looking at. The neuroscience of semax is more interesting than most TikTok peptide content admits, but the clinical evidence base is thin and largely confined to Russian research from the 1990s and 2000s.
Semax is a synthetic heptapeptide derived from ACTH(4-7). Animal studies show it increases BDNF and NGF expression in the brain, and some Russian clinical work suggests cognitive benefits in stroke recovery contexts (Selivanova et al., 2003, Zhurnal Nevrologii i Psikhiatrii). The dopamine-adjacent mechanism the creator describes is plausible: semax appears to modulate the dopaminergic system, particularly in the striatum, without directly binding dopamine receptors (Dolotov et al., 2006, Journal of Neurochemistry).
His comparison to modafinil, a wakefulness agent that works primarily through dopamine transporter inhibition, is a reasonable lay approximation. His claim that semax is not comparable to Adderall in terms of inertia-breaking is also defensible. There is no published human trial showing semax reliably produces the catecholamine surge that amphetamine salts do.
What did they get wrong, or right?
He got a few things meaningfully right and a few things wrong enough to flag.
Right
- "It's not as similar to Adderall as people make it seem." Correct. Adderall forces norepinephrine and dopamine release. Semax doesn't do that. Comparing them is apples to tractors.
- Calling it a short-acting, cleaner focus aid is consistent with user reports and the known half-life of semax nasal spray, which is quite short.
- Noting that selank lacks benzo-level side effects is accurate. Selank is structurally related to tuftsin and does not bind GABA-A receptors the way benzodiazepines do.
Wrong or at least unsupported
- The "habit enhancer" framing is creative but not scientifically established. There are no peer-reviewed human studies showing semax selectively reinforces habit loops. This is anecdote dressed as mechanism.
- Stacking semax with Adderall without mentioning any safety considerations is irresponsible. Combining a dopaminergic peptide with amphetamine salts in an unmonitored setting carries real cardiovascular and psychiatric risk.
- Bromantane as a "replacement for Adderall" is speculative and unsupported by clinical data in ADHD populations. One small Russian study (Morozov et al., 2010, Eksperimental'naya i Klinicheskaya Farmakologiya) looked at asthenia, not ADHD.
What should you actually know?
Semax is not approved by the FDA. It is not a scheduled substance in the US, but it exists in a regulatory gray zone. It is approved in Russia and Ukraine for neurological indications including stroke and optic nerve disease, not ADHD.
The studies that do exist are mostly preclinical or conducted in clinical populations with acute neurological injury, not healthy adults optimizing cognition. Translating those findings to a 25-year-old who wants to be more productive is a significant leap that the existing literature does not support.
If you have diagnosed ADHD, semax is not a validated treatment. The evidence for FDA-approved ADHD medications, stimulant and non-stimulant, is substantial and replicated across decades of randomized controlled trials. Semax does not have that evidence base.
The creator's personal experience is honest and relatively measured compared to most peptide content. But personal experience is not a clinical outcome, and three vials over three months is not a controlled experiment. Anyone considering semax should do so under the supervision of a licensed provider who can assess individual risk, not based on a TikTok review.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
theslickric · TikTok creator
14.9K views on this video
#semax #peptide #adhd #limitless #nootropic
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about semax?
Semax is FDA-unapproved and exists in a US regulatory gray zone. It is approved only in Russia and Ukraine, for stroke and optic nerve conditions, not ADHD.
What does the video say about the primary human evidence for semax comes from russian clinical?
The primary human evidence for semax comes from Russian clinical studies in acute neurological injury patients, not healthy adults seeking cognitive enhancement. This is a significant population mismatch.
Dolotov et al. (2006, Journal of Neurochemistry) confirmed semax modulates dopaminergic signaling and increases BDNF in animal models, which offers a plausible mechanism for the mild focus effect the creator described, but animal data does not equal human clinical benefit?
Dolotov et al. (2006, Journal of Neurochemistry) confirmed semax modulates dopaminergic signaling and increases BDNF in animal models, which offers a plausible mechanism for the mild focus effect the creator described, but animal data does not equal human clinical benefit.
What does the video say about comparing semax to adderall?
Comparing semax to Adderall or Ritalin for ADHD is not supported by any clinical evidence. FDA-approved ADHD medications have decades of replicated randomized controlled trial data behind them. Semax has none for this indication.
What does the video say about stacking semax with prescription amphetamines without medical supervision?
Stacking semax with prescription amphetamines without medical supervision is not a validated or safe protocol. The cardiovascular and psychiatric risks of combining dopaminergic agents in an unmonitored setting are real and unquantified.
What does the video say about selank,?
Selank, which the creator also tried, is a synthetic analog of tuftsin with anxiolytic properties studied in Russian literature. It does not act on GABA-A receptors like benzodiazepines, so the side-effect comparison to benzos is directionally fair, but it is not a validated anxiolytic substitute.
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by theslickric, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.